A first-in-human, Phase I/II, open-label study to evaluate the safety, tolerability, pharmacokinetics and preliminary antitumour activity of EMB-06 in patients with recurrent or refractory multiple myeloma

  • Kenealy, Melita (Primary Chief Investigator (PCI))
  • Lai, Li Hoon (Project Manager)

Project: Research

Project Details

Effective start/end date20/09/2131/12/24


  • Multiple myeloma
  • Haematological tumours
  • Haematological malignancy
  • Clinical trial